Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.04
1.05 (1.91%)
At close: Aug 15, 2025, 3:59 PM
56.07
0.05%
After-hours: Aug 15, 2025, 04:34 PM EDT
Protagonist Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 52.04M | 56.19M | 275.19M | 170.85M | 169.95M | 162.11M | -78.95M | -140.48M | -137.61M | -140.19M | -127.39M | -130.11M | -132.68M | -122.48M | -125.55M | -107.53M | -81.49M | -70.07M |
Depreciation & Amortization | 1.73M | 2.31M | 2.9M | 3.19M | 3.37M | 3.3M | 3.31M | 3.32M | 3.35M | 3.37M | 3.37M | 3.35M | 3.2M | 2.98M | 2.77M | 2.59M | 2.51M | 2.53M |
Stock-Based Compensation | 43.97M | 42M | 37.55M | 35.06M | 31.66M | 31.06M | 29.29M | 28.2M | 27.39M | 25.85M | 24.2M | 23.71M | 22.54M | 19.67M | 16.39M | 13.34M | 10.45M | 8.51M |
Other Working Capital | -3.61M | -31.06M | 31.55M | 16.98M | 23.37M | 35.57M | -16.68M | -2.62M | -10.68M | 11.25M | -9.81M | -5.29M | 5.21M | -23.3M | -1.92M | -7.87M | -25.46M | -27.37M |
Other Non-Cash Items | 113.87M | -296.33M | 264K | 1.68M | 10.31M | 300.08M | 2.43M | 2.86M | -3.02M | -1.97M | -549K | 874K | 1.46M | 1.84M | 1.83M | 1.65M | 1.24M | 699K |
Deferred Income Tax | n/a | n/a | n/a | 6.8M | n/a | n/a | n/a | -6.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34K | 26K | 1.25M |
Change in Working Capital | -170.35M | 245.41M | -122.61M | 28.65M | 32.19M | -254.86M | -19.51M | -5.93M | -7.52M | 8.12M | -7.77M | -1.27M | -1.23M | -18.79M | -3.31M | -9.87M | -20.35M | -28.32M |
Operating Cash Flow | 39.54M | 336.94M | 184.15M | 230.29M | 231.54M | -63.32M | -70.24M | -118.83M | -117.42M | -104.82M | -108.14M | -103.44M | -106.71M | -116.78M | -107.86M | -99.79M | -87.61M | -85.39M |
Capital Expenditures | -2.44M | -1.66M | -1.35M | -1.06M | -693K | -841K | -609K | -660K | -418K | -532K | -795K | -921K | -1.02M | -1.23M | -1.1M | -1.03M | -840K | -473K |
Cash Acquisitions | n/a | n/a | n/a | 61.27M | 74.42M | 48.48M | 38.65M | -26.62M | -97.22M | -106.3M | -96.47M | -92.46M | -35.02M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -662.27M | -770.07M | -621.7M | -605.26M | -397.55M | -228.66M | -191.04M | -173.67M | -146.88M | -187.1M | -214.87M | -164.97M | -225.25M | -255.22M | -286.59M | -388.33M | -376.73M | -346.35M |
Sales Maturities Of Investments | 407.69M | 371.77M | 323.57M | 254.28M | 241.35M | 186.48M | 152.4M | 200.3M | 244.09M | 293.4M | 307.14M | 281.29M | 239.69M | 242.91M | 271.83M | 271.23M | 250.03M | 206.33M |
Other Investing Acitivies | -5K | -88.09M | -81.78M | -143.05M | -156.2M | -42.17M | -38.65M | 26.62M | 97.22M | 106.3M | 92.26M | 116.32M | 14.44M | -12.31M | -14.76M | -117.1M | -126.7M | -140.01M |
Investing Cash Flow | -257.03M | -399.96M | -299.48M | -352.05M | -156.89M | -43.01M | -39.26M | 25.96M | 96.8M | 105.77M | 91.47M | 115.4M | 13.42M | -13.54M | -15.86M | -118.13M | -127.54M | -140.49M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 600K | 600K | n/a | n/a | -600K | -600K | n/a | n/a | -2K | -2K | -2K | -2K | n/a | n/a | -189K | -189K | -189K | -189K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 30.45M | 30.1M | 25.85M | 22.34M | 45.6M | 43.34M | 38.3M | 38.33M | 3.7M | 4.07M | 4.29M | 5.91M | 6.61M | 7.32M | 5.93M | 4.07M | 4.18M | 115.36M |
Financial Cash Flow | 30.45M | 30.1M | 25.85M | 22.35M | 45.61M | 151.21M | 170.48M | 170.5M | 135.87M | 28.38M | 18.84M | 20.46M | 21.16M | 145.87M | 129.92M | 254.73M | 261.02M | 248.21M |
Net Cash Flow | -187.03M | -32.91M | -89.48M | -99.41M | 120.26M | 44.88M | 60.98M | 77.71M | 115.14M | 29.21M | 2.08M | 32.27M | -72.17M | 15.48M | 6.07M | 36.68M | 45.94M | 22.55M |
Free Cash Flow | 37.1M | 335.29M | 182.8M | 229.23M | 230.85M | -64.16M | -70.84M | -119.49M | -117.84M | -105.35M | -108.93M | -104.36M | -107.73M | -118.01M | -108.97M | -100.82M | -88.45M | -85.86M |